钙网蛋白在心肌肥大中的研究进展

钙网蛋白(calreticulin, CRT)是内质网中主要的Ca2+结合分子伴侣,具有调控细胞Ca2+稳态、蛋白质合成与修饰等作用,参与调节细胞凋亡、应激、心血管炎症反应等多种生理和病理生理过程.CRT属于心脏胚胎基因家族,通过调节心肌细胞肌原纤维形成、促进糖原分解、诱导肥大相关基因转录、调节心脏传导系统发育及心肌细胞凋亡等,在心脏发育及心肌肥大的发生、发展过程起重要作用,本文对CRT在心肌肥大中的作用及其信号转导途径予以综述.     

压力超负荷心肌肥大晚期和心衰大鼠心肌力学及Ca^2＋反？…

目的：观测比较肥大心肌和衰竭心肌在基础力学性能、「Ｃａ＾２＋」。正性变力作用和Ｃａ＾２＋通道阻滞剂负性变力作用三方面的变化和差别。方法：大鼠升主动脉缩窄法建立左心室肥大（ＬＶＨ）和充血性心衰（ＣＨＦ）模型,记录离体灌流乳头肌的和长度－张力曲线,比较基础状态和ｎｉｒｉｄｉｐｉｎｅ处理后「Ｃａ＾２＋」。与峰张力的量效关系。结果：①ＣＨＦ组长度－张力曲线料ＬＶＨ组和假手术对照组（Ｓｈａｍ）明显下移;基础     

钙网蛋白研究进展

钙网蛋白研究进展陈安和（西南师范大学生命科学系,重庆６３０７１５）关键词钙网蛋白钙网蛋白（ｃａｌｒｅｔｉｃｕｌｉｎ）是１９７４年命名的骨骼肌肌质网膜上的钙结合蛋白。近年的研究发现,该蛋白质在非肌肉组织中含量丰富,它是内质网（ＥＲ）主要的钙结合蛋白之一...     

植物细胞中钙信号的时空多样性与信号转导

近年来,对钙信号的研究,包括对钙信号的产生,传导及最终靶蛋白的研究,越来越受到人们的重视,植物生长发育过程的信息传递,包括对各种内外刺激的反应都涉及到钙信号,钙信号的产生及传导是通过胞质自由钙离子的浓度变化来实现的,本文综述了胞质自由钙离子的测定,钙信号的时空多样性及钙信号的靶蛋白如CaM,Ca^2 依赖的蛋白激酶,钙调磷酸酶,磷脂酰肌醇－磷脂酶C等方面的一些最新进展,展望了今后钙信号研究的方向所用到的一些技术方法等。     

钙网蛋白的生理及病理生理学作用

钙网蛋白（calreticulin,CRT）是内质网／肌浆网主要的Ca2^＋结合蛋白,通过协助蛋白质正确折叠和维持细胞Ca^2＋稳态而参与调节细胞凋亡、黏附、类固醇敏感性基因表达和自身免疫反应等,并与多种人类疾病的发生、发展和预后相关。本文综述钙网蛋白的生理功能及其在心肌肥大与衰竭、血管新生和应激等病理状态下的变化。     

中枢神经系统钙稳态失调和老龄脑功能

脑的老化表现为记忆力的减退。脑老化的钙假说认为脑的老化与中枢神经系统「Ｃａ＾２＋」ｉ的调节机制紊乱有关,衰老可以通过多种因素导致「Ｃａ＾２＋」ｉ升高,影响突触传导,神经递质释放,信号转导等导致记忆障碍,本文综述了近年来的进展。     

钙网蛋白的免疫生物学活性研究进展

钙网蛋白(calreticulin,CRT)是内质网中的Ca2+结合蛋白,对维持细胞内的Ca2+稳态具有重要作用。CRT还可作为分子伴侣,帮助新合成的内质网蛋白正确折叠。除此之外,CRT还出现在细胞膜表面及细胞外环境中,并发挥重要的免疫调节作用。膜表面的CRT参与凋亡细胞的清除和抗肿瘤免疫应答,在T细胞活化早期也发挥重要作用。可溶性CRT出现在自身免疫病患者的血清中,且其浓度与疾病活动度相关。重组可溶性CRT腹腔注射可显著影响小鼠的Th1/Th2平衡。重组可溶性CRT分子不仅具有超强免疫刺激活性,还表现出很强的佐剂效应,提示可溶性CRT可能在自身免疫性疾病的发生与发展过程中发挥一定作用。可以预见,CRT分子的免疫生物学活性将在不久的将来成为该领域研究的一个热点。     

钙信号基本单位和特征的研究进展

细胞内存在多种不同的Ｃａ＾２＋信号基本单位,这些Ｃａ＾２＋信号基本单位依赖于刺激浓度的等级体系组织。低水平的刺激激活单通道开放,产生Ｃａ＾２＋脉冲或Ｃａ＾２＋夸克;在等组织水平刺激则产生喷烟和火花,似乎与一小簇通道的激活有关;高浓度刺激时,Ｃａ＾２＋信号基本单位协同产生球形Ｃａ＾２＋波。这些Ｃａ＾２＋基本单位既本现了钙释放单位（Ｃａ＾２＋ｒｅｌｅａｓｅ ｕｎｉｔ）的特征,又导致Ｃａ＾２＋信号传播在     

钙调神经磷酸酶依赖的信号通路在大鼠心肌肥大中的作用及调节

本工作在大体动物模型、细胞及分子水平上,对钙调神经磷酸酶（CaN)依赖的信号通路在大鼠豳肥大中的作用及其调节机制进行了研究。结果发现;（１）ＣaN信号通路参与血流动力学超负荷、心肌纤维化、旁／自分泌因子等诱导的心肌细胞肥大;（２）ＣaN信号通道参与血管紧张素Ⅱ(AngⅡ)及碱性成纤维细胞因子(bFGF)诱导的心肌细胞肥大和AngⅡ及bFGF刺激的心脏成纤维细胞增殖;（３）ＣaN通路与丝裂素活化蛋白激酶（ＭＡＰＫ）及蛋白激酶Ｃ（ＰＫＣ）信号途径可能存在相互关系;（４）ＣaN的活化依赖胞内Ｃa^2 浓度的持续升高,ＣaN的活化还受蛋白激酶磷酸化的调节,ＡngⅡ刺激心肌细胞ＣaNmRNA的表达显著增加,ＣaNmRNA本身的表达受Ｃa^2 信号及ＭＡＰＫ级联反应的调控。结论：Ｃa^2 -ＣaN信号通路介导心肌肥大的发生。     

有氧运动诱导心肌肥大和心肌细胞增殖的研究进展

适宜的运动负荷可刺激心肌生理性肥大和心肌细胞增殖,但这种内源性生理过程的分子机制知之甚少,因此有氧运动诱导心肌肥大和心肌细胞增殖的研究是目前发育生物学和细胞生物学领域的热点,其具体分子机制以及生理价值具有重要的生物学和医学研究及应用意义。该文综述了近年来有氧运动诱导心肌肥大和心肌细胞增殖的研究进展,旨在为相关领域的研究提供参考。     

半翼基因的研究进展

在果蝇体内人们发现半翼基因(wings apart-like,wapl)所编码的蛋白具有调节异染色质结构的功能。人半翼基因(human wings apart-like,hwapl)是wapl的同源基因,两者具有相似的功能,能够与黏连蛋白结合,并且调节姐妹染色单体的分离。此外,其还具有癌基因的特性,与宫颈癌的发展有关。     

微小RNA介导心肌纤维化信号通路的研究进展

心肌纤维化以细胞外基质沉积为主要特征,是许多心血管疾病发展到一定阶段的共同病理变化.心肌纤维化过程中的一些微小RNA(microRNAs,miRNAs)表达异常,并通过对多种信号通路的调控,参与心肌成纤维细胞的活化和增殖过程,从而介导心肌纤维化的发生和发展.本文将综述这些miRNAs在心肌纤维化中的作用和机制,为心肌纤...     

内质网应激与心肌肥大

肌浆网是调控心肌细胞钙稳态、蛋白质合成和细胞凋亡的重要亚细胞器。内质网应激是指内质网理化环境改变和过负荷等因素导致未折叠/误折叠蛋白在内质网聚集和钙稳态失衡等内质网功能紊乱状态。适度的内质网应激有利于心肌细胞代偿,持续而严重的内质网应激则触发内质网应激相关细胞凋亡,造成肥大心肌由代偿转向衰竭,是影响心肌肥大发生、发展的重要因素。本文综述了内质网应激反应在心肌肥大发生、发展中的作用。     

耐辐射异常球菌抗辐射机理的研究新进展

报道了自1956年Anderson发现耐辐射异常球菌(Deinococcusradiodurans)以来,国外在其生理生化和遗传学特性、特殊的细胞膜结构、各种诱变因素所致的DNA损伤与其高效的修复机制和生物化学、分子生物学应用于该菌的研究新进展。对该菌的研究在辐射生物学与医学上具有特殊的意义,因此,我国的辐射生物学、微生物学和医学研究人员应尽快开展这方面的研究。     

Role of myofibrillogenesis regulator-1 in myocardial hypertrophy

Myofibrillogenesis regulator-1 (MR-1) is a novel homologous gene, identified from a human skeletal muscle cDNA library, that interacts with contractile proteins and exists in human myocardial myofibrils. The present study investigated MR-1 protein expression in hypertrophied myocardium and MR-1 involvement in cardiac hypertrophy. Cardiac hypertrophy was induced by abdominal aortic stenosis (AAS) in Sprague-Dawley rats. Left ventricular (LV) hypertrophy was assessed by the ratio of LV wet weight to whole heart weight (LV/HW) or LV weight to body weight (LV/BW). Rat MR-1 (rMR-1) expression in the myocardium was detected by immunohistochemical and Western blotting analysis. Hypertrophy was induced by ANG II incubation in cultured neonatal rat cardiomyocytes. The effect of rMR-1 RNA interference on ANG II-induced hypertrophy was studied by transfection of cardiomyocytes with an RNA interference plasmid, pSi-1, which targets rMR-1. Hypertrophy in cardiomyocytes was assessed by [3H]Leu incorporation and myocyte size. rMR-1 protein expression in cardiomyocytes was detected by Western blotting. We found that AAS resulted in a significant increase in LV/HW and LV/BW: 89% and 86%, respectively (P < 0.01). Immunohistochemistry and Western blot analysis demonstrated upregulated rMR-1 protein expression in hypertrophic myocardium. ANG II induced a 24% increase in [3H]Leu incorporation and a 65.8% increase in cell size compared with control cardiomyocytes (P < 0.01), which was prevented by treatment with losartan, an angiotensin (AT1) receptor inhibitor, or transfection with pSi-1. rMR-1 expression increased in ANG II-induced hypertrophied cardiomyocytes, and pSi-1 transfection abolished the upregulation. These findings suggest that MR-1 is associated with cardiac hypertrophy in rats in vivo and in vitro.     

Ploidies of cardiomyocytes in human myocardial hypertrophy]

DNA cytophotometry has been performed in ventricular cardiomyocytes of hypertrophic human hearts. In the cases of hypertrophy in adults (generalized atherosclerosis, postinfarct scars), polyploidy expression did not exceed the limits of normal variability developed during childhood. In the cases of hypertrophy caused by congenital heart defects, high polyploidy has been revealed (the mean level 20c and more, where c is haploid DNA content), which considerably exceeded the upper limit of normal variability (approximately 10c). Our hypothesis has confirmed that heart hypertrophy in adults proceeds in conditions of stable genome rather than due to redundant polyploidization of the ventricular myocytes. The same idea assumes enhanced polyploidization of the myocytes in childhood in humans with congenital heart diseases.     

Inhibitory effects of interferon-gamma on myocardial hypertrophy

Prostaglandin F(2alpha) (PGF(2alpha)) plays an important role in pathologic cardiac growth. After testing several immune cytokines, we found that interferon-gamma (IFN-gamma) inhibited responsiveness of adult myocytes to PGF(2alpha). The present study was designed to test the hypothesis that IFN-gamma inhibits cardiac hypertrophy induced by PGF(2alpha). Incubation of cultured adult rat cardiac myocytes with PGF(2alpha) caused cell spreading, which was inhibited by IFN-gamma. The inhibitory effect was not affected by nitric oxide (NO) synthase inhibitors. In addition, administration of fluprostenol, a more selective agonist at the PGF(2alpha) receptor, induced cardiac hypertrophy in rats. Chronic treatment with IFN-gamma inhibited this myocardial growth, and the inhibitory effect of IFN-gamma was not accompanied by an increase in myocardial NO synthase gene expression. Further, abdominal aortic constriction resulted in a substantial increase in heart, ventricular and left ventricular weights to BW ratio that was significantly attenuated by treatment with IFN-gamma. The results demonstrate that IFN-gamma inhibits the in vitro and in vivo effects of PGF(2alpha) on cardiac hypertrophy, and that the mechanism of action is likely independent of NO production. IFN-gamma also attenuated cardiac hypertrophy induced by pressure overload, suggesting that PGF(2alpha) plays a role in the pathogeneses of this severe type of cardiac hypertrophy.